“Drug Pricing”

23 result(s)
Cost Management
As part of the CVS Health hyperinflation strategy, our Outlier Pharmacy Program proactively monitors and identifies pharmacies with increased volume in claims submissions of... More
Briefing
Cost Management
Our job at CVS Caremark is to be the best manager of our clients’ pharmacy spend, which includes better engaging patients and their providers throughout the duration of therapy,... More
Feature
A couple stroll together on the beach
Cost Management
In 2019, drug trend for CVS Caremark pharmacy benefit clients was a historically low, industry-leading 1.4 percent, with 41% of clients seeing negative trend. Specialty trend was... More
Feature
Cost Management
Payors are projected to save on per-member-per-month costs from strategic formulary removals designed to help mitigate the effect of high-cost and hyperinflationary drugs More
Briefing
Public Policy
Our perspective offered to Congress on solutions and policies that can help bring escalating drug prices under control. More
Commentary
Father and son
Cost Management
As a health care innovation company, our steadfast focus is on helping to reduce costs and improve outcomes for our pharmacy benefit management (PBM) clients and their plan... More
Feature
Public Policy
Solutions such as POS rebates and $0 copay drug lists can lower costs for plans and consumers, while a one-size-fits-all approach could lead to unintended consequences, and higher... More
Briefing
Twisting mountain road in the Swiss alps
Public Policy
Proposed HHS rule would eliminate rebates PBMs negotiate for Part D plans and MCOs, and may eventually affect all plans. Manufacturers would retain 15% of rebates currently... More
Briefing
A glass of water and two pills
Cost Management
It's time to bust the myth about drug prices and rebates. Larry Merlo, President and CEO shared CVS Health’s perspective as an employer and PBM in an op-ed. More
Commentary
Sitting man holding two pills and a glass of water
Cost Management
CVS Health responded to the Administration's Blueprint on lowering drug costs and highlighted what the company does to control costs. We also recommended things the... More
Commentary